Phase 2 of HU-045 in Glabellar Lines

PHASE2CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

March 28, 2022

Primary Completion Date

November 7, 2022

Study Completion Date

April 25, 2023

Conditions
Glabellar Lines
Interventions
DRUG

HU-045

"HU-045 is a medicine that is injected into muscles and used to improve the look of moderate to severe frown lines between the eyebrows (glabellar lines) in adults for a short period of time (temporary). It should be reconstituted with sterile, preservative-free 0.9% saline before use.~White powder"

DRUG

Xeomin®

Xeomin® is a prescription medicine that is injected into muscles and used to improve the look of moderate to severe frown lines between the eyebrows (glabellar lines) in adults for a short period of time (temporary). It should be reconstituted with sterile, preservative-free 0.9% saline before use.

Trial Locations (1)

Unknown

Chung-Ang University, Seoul

All Listed Sponsors
lead

Huons Co., Ltd.

INDUSTRY